Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2008-07-21 Capital/Financing Update
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Acquisition of Frozen Puppies Dot Com 10 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated July 22, 2008, regarding the acquisition of Frozen Puppies Dot Com Pty. Ltd. by Genetic Technologies Limited. It details the terms of the acquisition, including share issuance and cash payment, and includes an Appendix 3B which is a New Issue Announcement form used for notifying the ASX of new securities issued. The document primarily focuses on the capital raising and share issuance related to the acquisition. It is not a full financial report, earnings release, or management discussion, but rather an announcement of a capital/financing event and related securities issuance. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the share issuance and acquisition terms, supporting a high confidence classification.
2008-07-21 English
Enforcement of BRCA rights 1 page ?Kb
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated July 11, 2008, regarding Genetic Technologies Limited's commercial decision to enforce rights to BRCA patents under an exclusive license. It discusses business strategy and operational details but does not contain financial statements, audit information, or regulatory certifications. The document is relatively short (3482 characters) and serves as a public announcement of a business decision rather than a detailed report or financial filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a regulatory filing or certification. The content aligns best with a general regulatory announcement about company operations and strategy, which fits the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2008-07-10 English
Appendix 3B 9 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is an ASX announcement dated June 30, 2008, regarding the granting and cancellation of options by Genetic Technologies Limited. It includes detailed information on the number of options granted and cancelled, exercise prices, expiry dates, and an attached Appendix 3B form. Appendix 3B is a standard form used for new issue announcements and applications for quotation of additional securities on the ASX. The content focuses on securities issuance and capital changes rather than financial results, management changes, or other report types. The document is not a full financial report, earnings release, or management discussion but a regulatory announcement about capital changes. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement or a report publication notice but a substantive capital change filing.
2008-06-29 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of shares/options held before and after the change, nature of the transaction, and dates. This matches the definition of a Director's Dealing report, which involves personal share transactions by company directors and executives. The document length is short and focused solely on director share transactions, with no financial statements or other report content. Therefore, the correct classification is Director's Dealing (DIRS).
2008-05-19 English
Appendix 4C - quarterly 8 pages ?Kb
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 March 2008.' It contains detailed financial data including consolidated statements of cash flows, operating activities, investing activities, financing activities, and reconciliation of cash. The document also includes operational summaries and corporate matters relevant to the quarter. The presence of Appendix 4C, which is a standard quarterly report format for entities admitted on the basis of commitments under ASX rules, confirms this is a quarterly report. The document is comprehensive and contains substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. It is not an announcement or a brief summary, nor is it a full annual report or earnings release. Therefore, the correct classification is Interim / Quarterly Report (IR). Q3 2008
2008-04-27 English
Management update 1 page ?Kb
Board/Management Information Classification · 95% confidence The document is an ASX announcement dated April 23, 2008, titled 'Management update'. It announces two key executive appointments and a departure of a Chief Scientific Officer. There is no financial data, no mention of financial results, no regulatory certifications, or report attachments. The content focuses solely on changes in senior management personnel. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under 'Board/Management Information' (MANG). The document length is short (2677 characters), and it is clearly a management update, not a report or announcement of a report publication. Therefore, the correct classification is MANG with high confidence.
2008-04-22 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.